CAS 98319-26-7
:Finasteride
Description:
Finasteride is a synthetic pharmaceutical compound primarily used in the treatment of benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness). It functions as a 5-alpha-reductase inhibitor, blocking the conversion of testosterone to dihydrotestosterone (DHT), a hormone implicated in both conditions. The molecular formula of finasteride is C23H36N2O2, and it has a molecular weight of approximately 372.55 g/mol. The substance appears as a white to off-white crystalline powder and is typically administered orally. Finasteride is known for its relatively high bioavailability and is metabolized primarily in the liver. Common side effects may include sexual dysfunction, gynecomastia, and mood changes, although these are not experienced by all users. Due to its mechanism of action, finasteride is contraindicated in women, particularly during pregnancy, as it can cause fetal harm. Overall, finasteride is a significant medication in urology and dermatology, providing therapeutic benefits for conditions related to DHT.
Formula:C23H36N2O2
InChI:InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1
InChI key:InChIKey=DBEPLOCGEIEOCV-WSBQPABSSA-N
SMILES:C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@@](CC3)(NC(=O)C=C4)[H])(CC1)[H])[H])(CC[C@@H]2C(NC(C)(C)C)=O)[H]
Synonyms:- (4aR,4bS,6aS,7S,9aS,9bS)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,4bS,6aS,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
- 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5α,17β)-
- Appecia
- Chibro-Proscar
- Finalo
- Finara
- Finast
- Finasterid Alternova
- Finastid
- Finax
- Fincar
- Finpecia
- Fistide
- Geffina
- Mk 906
- N-(2-Methyl-2-Propyl)-3-Oxo-4-Aza-5Alpha-Androst-1-Ene-17Beta-Carboxamide
- N-(tert-Butyl)-3-oxo-4-aza-5α-androst-1-ene-17-carboxamide
- Propecia
- Proscar
- Prosteride
- Prostide
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Finasteride
CAS:Formula:C23H36N2O2Purity:>98.0%(GC)Color and Shape:White to Almost white powder to crystalMolecular weight:372.55Finasteride
CAS:FinasterideFormula:C23H36N2O2Purity:99.9%Color and Shape:WhiteMolecular weight:372.27768Finasteride
CAS:Adrenal cortical hormones and their derivatives nesoiFormula:C23H36N2O2Color and Shape:White Off-White PowderMolecular weight:372.27768N-tert-Butyl-3-oxo-4-aza-5α-androst-1-en-17β-carboxamide
CAS:Formula:C23H36N2O2Purity:98%Color and Shape:SolidMolecular weight:372.5441Finasteride
CAS:<p>Finasteride (MK-906) is an oral inhibitor of active testosterone 5-alpha-reductase and Ki value is 10 nM.</p>Formula:C23H36N2O2Purity:99.04% - 99.97%Color and Shape:White To Off-White Crystalline PowderMolecular weight:372.54Finasteride, USP grade
CAS:Formula:C23H36N2O2Purity:≤ 0.5%Color and Shape:White or almost white powderMolecular weight:372.54Finasteride
CAS:Formula:C23H36N2O2Purity:98.5 - 101.0 % (anhydrous basis)Color and Shape:White to off-white crystalline powderMolecular weight:372.54Finasteride, EP grade
CAS:Formula:C23H36N2O2Purity:≤ 0.1%Color and Shape:White to almost white crystalline powderMolecular weight:372.54Finasteride
CAS:Controlled ProductFormula:C23H36N2O2Color and Shape:White To Off-WhiteMolecular weight:372.54Finasteride
CAS:<p>Inhibitor of 5α-reductase 5AR2; inhibitor of dihydrotestosterone synthesis</p>Formula:C23H36N2O2Purity:Min. 98 Area-%Color and Shape:White Off-White PowderMolecular weight:372.54 g/molFinasteride - Bio-X ™
CAS:<p>Finasteride is an antiandrogenic drug that belongs to the group of 5-alpha reductase inhibitors, which are used for the treatment of benign prostatic hyperplasia and male pattern baldness. The conversion of testosterone to 5α-dihydrotestosterone (DHT) is blocked by type II 5α-reductase inhibition, which then results in significant increase in prostatic testosterone concentrations and minimal to moderate increases in serum and tissue DHT concentrations. A reduction in DHT concentration will cause a reduction in prostatic volume as DHT appears to be the main androgen responsible for stimulating prostatic growth.</p>Formula:C23H36N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:372.54 g/mol















